Organon & Co. (OGN) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown
OGN's revenue distribution by segment and geography
By Geography
OGN Revenue Analysis (2018–2025)
As of March 2, 2026, Organon & Co. (OGN) generated trailing twelve-month (TTM) revenue of $6.22 billion, reflecting moderate decline in growth of -5.3% year-over-year. The most recent quarter (Q4 2025) recorded $1.51 billion in revenue, down 5.9% sequentially.
Looking at the longer-term picture, OGN's 5-year compound annual growth rate (CAGR) stands at -1.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $9.78 billion in 2018.
When compared to Healthcare sector peers including NVS (+8.6% YoY), and SRXH, OGN has underperformed the peer group in terms of revenue growth. Compare OGN vs NVS →
Peer Comparison
Compare OGN's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| OGNCurrent | $6.2B | -5.3% | -1.0% | 20.7% | |
| NVS | $54.8B | +8.6% | +1.9% | 31.2% | |
| SRXH | $119M | - | - | -4.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.22B | -2.9% | $3.36B | 54.1% | $1.28B | 20.7% |
| 2024 | $6.40B | +2.2% | $3.71B | 58.0% | $1.49B | 23.2% |
| 2023 | $6.26B | +1.4% | $3.75B | 59.8% | $1.33B | 21.2% |
| 2022 | $6.17B | -2.1% | $3.88B | 62.8% | $1.71B | 27.6% |
| 2021 | $6.30B | -3.5% | $3.92B | 62.2% | $1.92B | 30.4% |
| 2020 | $6.53B | -16.0% | $4.41B | 67.6% | $2.85B | 43.6% |
| 2019 | $7.78B | -20.5% | $5.50B | 70.8% | $3.85B | 49.5% |
| 2018 | $9.78B | - | $5.08B | 52.0% | $2.71B | 27.7% |
See OGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OGN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare OGN vs AGIO
See how OGN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is OGN's revenue growth accelerating or slowing?
OGN revenue declined -5.3% year-over-year, contrasting with the 5-year CAGR of -1.0%. TTM revenue fell to $6.2B. This reverses the prior growth trend.
What is OGN's long-term revenue growth rate?
Organon & Co.'s 5-year revenue CAGR of -1.0% reflects the variable expansion pattern. Current YoY growth of -5.3% is below this long-term average.
How is OGN's revenue distributed by segment?
OGN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.